LMK-235

CAS No. 1418033-25-6

LMK-235 ( LMK 235;LMK 235 )

Catalog No. M11747 CAS No. 1418033-25-6

A selective HDAC5 and HDAC4 inhibitor with IC50 of 4.22 nM and 11.9 nM respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 41 In Stock
10MG 65 In Stock
25MG 128 In Stock
50MG 222 In Stock
100MG 402 In Stock
200MG 593 In Stock
500MG 888 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LMK-235
  • Note
    Research use only, not for human use.
  • Brief Description
    A selective HDAC5 and HDAC4 inhibitor with IC50 of 4.22 nM and 11.9 nM respectively.
  • Description
    A selective HDAC5 and HDAC4 inhibitor with IC50 of 4.22 nM and 11.9 nM respectively; less potent for HDAC1/11/2/8; demonstrates activity against chemoresistant cancer cell lines in an MTT assay for cytotoxicity using human ovarian cancer cell lines A2780 and cisplatin resistant A2780CisR (IC50 =0.49 and 0.32 uM respectively).
  • Synonyms
    LMK 235;LMK 235
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC4;HDAC5
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1418033-25-6
  • Formula Weight
    294.35
  • Molecular Formula
    C15H22N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 30 mg/mL
  • SMILES
    O=C(NOCCCCCC(NO)=O)C1=CC(C)=CC(C)=C1
  • Chemical Name
    Benzamide, N-[[6-(hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Marek L, et al. J Med Chem. 2013 Jan 24;56(2):427-36.
2. Li A, et al. Eur J Pain. 2013 Sep;17(8):1156-67.
molnova catalog
related products
  • ACY-1083

    ACY-1083 is a selective and brain-penetrating HDAC6 inhibitor (IC50: 3 nM). It is 260-fold more selective for HDAC6 than all other classes of HDAC isoforms.

  • Ledipasvir

    Ledipasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor.

  • SS-208

    SS-208 is a selective inhibitor of HDAC6 (IC50 = 12 nM) with anti-tumor activity. SS-208 shows selectivity over other HDAC subtypes.